Medication info
Janustin 100 mg (Sitagliptin Hydrochloride Hydrate)

Janustin 100 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.37mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
Bright yellow-orange round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle - 30 tablets/bottle, 30 tablets/bottle, 100 tablets/bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 202102721 · Approved 2021.03.29 · Insurance code 665003190

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This drug is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This drug may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, reduction of the sulfonylurea or insulin dose may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before treatment with this drug and periodically thereafter. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2) should receive 50 mg once daily. 4. Patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2) should receive 25 mg once daily. This drug may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to help control blood sugar in patients with type 2 diabetes. It can be used as a monotherapy or as an adjunct to diet and exercise. It is administered in combination with metformin when monotherapy is insufficient for blood sugar control in patients without prior diabetes medication experience. Additionally, it can be added when adequate blood sugar control is not achieved with monotherapy of sulfonylurea, metformin, thiazolidinediones, or insulin. It can be used in adjunctive combination therapy to improve blood sugar control effectively.

Dosage and Administration

Adult dosage

This drug is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This drug may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, reduction of the sulfonylurea or insulin dose may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before treatment with this drug and periodically thereafter. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2) should receive 50 mg once daily. 4. Patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2) should receive 25 mg once daily. This drug may be administered regardless of the timing of dialysis.

Precautions

This medication may cause serious allergic reactions; therefore, if symptoms such as skin rash, difficulty breathing, or swelling of the face or throat occur after taking the medication, discontinue use immediately and consult a physician. Patients should monitor closely for symptoms of pancreatitis, such as severe abdominal pain or vomiting, or persistent abdominal pain while taking this medication, and should discontinue use and inform healthcare personnel if such symptoms are suspected. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication, nor should it be used by those allergic to the drug or its components. Patients with reduced kidney function should take a reduced dose of this medication and undergo regular kidney function tests. In clinical trials, patients taking this medication reported side effects similar to cold and upper respiratory infections, headaches, nasopharyngitis, diarrhea, and nausea, along with some experiencing hypoglycemia. The risk of hypoglycemia may increase when this medication is taken in combination with other antidiabetic agents such as insulin or sulfonylureas, and blood sugar changes should be monitored closely. Patients may experience severe joint pain and should consult a physician and consider discontinuing the medication if symptoms occur. Additionally, rare instances of skin blisters or ulcers may occur, so patients should notify healthcare personnel immediately if any skin abnormalities arise. It is advised that pregnant or breastfeeding women avoid this medication, and safety and efficacy have not been established in individuals under the age of 18. Elderly patients may require dose adjustments and regular kidney function tests due to potential declines in kidney function. In the case of overdose, emergency treatment such as the removal of the drug from the gastrointestinal tract may be necessary, and blood dialysis could be considered as this medication can be partially removed by hemodialysis if necessary. Though interactions with other medications are limited, caution is advised when taken with digoxin or cyclosporine; therefore, consultation with healthcare personnel during usage is important.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • nasopharyngitis
  • upper respiratory infection
  • headache
  • diarrhea
  • abdominal pain
Show 28 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe arthritis with disability
  • blistering similar pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture exposure, and it is best kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Bright yellow-orange round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle - 30 tablets/bottle, 30 tablets/bottle, 100 tablets/bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.